JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaartinen, M. T.
Right arrow Articles by Mäenpää, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaartinen, M. T.
Right arrow Articles by Mäenpää, P. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 3, 1729-1735, January 15, 1999

Cross-linking of Osteopontin by Tissue Transglutaminase Increases Its Collagen Binding Properties

Mari T. Kaartinen, Arja Pirhonen, Annikka Linnala-Kankkunen, and Pekka H. Mäenpää

From the Department of Biochemistry and Biotechnology, University of Kuopio, FIN-70210 Kuopio, Finland

Osteopontin, a major noncollagenous bone protein, is an in vitro and in vivo substrate of tissue transglutaminase, which catalyzes formation of cross-linked protein aggregates. The roles of the enzyme and the polymeric osteopontin are presently not fully understood. In this study we provide evidence that transglutaminase treatment significantly increases the binding of osteopontin to collagen. This was tested with an enzyme-linked immunosorbent assay. The results also show that this increased interaction is clearly calcium-dependent and specific to osteopontin. In dot blot overlay assay 1 µg of collagen type I was able to bind 420 ng of in vitro prepared and purified polymeric osteopontin and only 83 ng of monomeric osteopontin, indicating that the transglutaminase treatment introduces a 5-fold amount of osteopontin onto collagen. Assays using a reversed situation showed that the collagen binding of the polymeric form of osteopontin appears to be dependent on its conformation in solution. Circular dichroism analysis of monomeric and polymeric osteopontin indicated that transglutaminase treatment induces a conformational change in osteopontin, probably exposing motives relevant to its interactions with other extracellular molecules. This altered collagen binding property of osteopontin may have relevance to its biological functions in tissue repair, bone remodeling, and collagen fibrillogenesis.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
K. A. Johnson, M. Polewski, and R. A. Terkeltaub
Transglutaminase 2 Is Central to Induction of the Arterial Calcification Program by Smooth Muscle Cells
Circ. Res., March 14, 2008; 102(5): 529 - 537.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. Hendig, M. Arndt, C. Szliska, K. Kleesiek, and C. Gotting
SPP1 Promoter Polymorphisms: Identification of the First Modifier Gene for Pseudoxanthoma Elasticum
Clin. Chem., May 1, 2007; 53(5): 829 - 836.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. T. Kaartinen, M. Murshed, G. Karsenty, and M. D. McKee
Osteopontin Upregulation and Polymerization by Transglutaminase 2 in Calcified Arteries of Matrix Gla Protein-deficient Mice
J. Histochem. Cytochem., April 1, 2007; 55(4): 375 - 386.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. Subramanian, P. Krishnamurthy, K. Singh, and M. Singh
Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H673 - H683.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
M.T. Kaartinen, W. Sun, N. Kaipatur, and M.D. McKee
Transglutaminase Crosslinking of SIBLING Proteins in Teeth
J. Dent. Res., July 1, 2005; 84(7): 607 - 612.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Diez
Profibrotic Effects of Angiotensin II in the Heart: A Matter of Mediators
Hypertension, June 1, 2004; 43(6): 1164 - 1165.
[Full Text] [PDF]


Home page
HypertensionHome page
Y. Matsui, N. Jia, H. Okamoto, S. Kon, H. Onozuka, M. Akino, L. Liu, J. Morimoto, S. R. Rittling, D. Denhardt, et al.
Role of Osteopontin in Cardiac Fibrosis and Remodeling in Angiotensin II-Induced Cardiac Hypertrophy
Hypertension, June 1, 2004; 43(6): 1195 - 1201.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
G. A. Johnson, R. C. Burghardt, F. W. Bazer, and T. E. Spencer
Osteopontin: Roles in Implantation and Placentation
Biol Reprod, November 1, 2003; 69(5): 1458 - 1471.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
G. A. Johnson, R. C. Burghardt, M. M. Joyce, T. E. Spencer, F. W. Bazer, C. A. Gray, and C. Pfarrer
Osteopontin Is Synthesized by Uterine Glands and a 45-kDa Cleavage Fragment Is Localized at the Uterine-Placental Interface Throughout Ovine Pregnancy
Biol Reprod, July 1, 2003; 69(1): 92 - 98.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. L. Myers, K. J. Harmon, V. Lindner, and L. Liaw
Alterations of Arterial Physiology in Osteopontin-Null Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2003; 23(6): 1021 - 1028.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Geissinger, C. Weisser, P. Fischer, M. Schartl, and C. Wellbrock
Autocrine Stimulation by Osteopontin Contributes to Antiapoptotic Signalling of Melanocytes in Dermal Collagen
Cancer Res., August 15, 2002; 62(16): 4820 - 4828.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. Rittling, Y. Chen, F. Feng, and Y. Wu
Tumor-derived Osteopontin Is Soluble, Not Matrix Associated
J. Biol. Chem., March 8, 2002; 277(11): 9175 - 9182.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Mavroidis and Y. Capetanaki
Extensive Induction of Important Mediators of Fibrosis and Dystrophic Calcification in Desmin-Deficient Cardiomyopathy
Am. J. Pathol., March 1, 2002; 160(3): 943 - 952.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Liu, R. A. Cerione, and J. Clardy
Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity
PNAS, February 20, 2002; (2002) 42454899.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J.M. Weiss, A.C. Renkl, C.S. Maier, M. Kimmig, L. Liaw, T. Ahrens, S. Kon, M. Maeda, H. Hotta, T. Uede, et al.
Osteopontin Is Involved in the Initiation of Cutaneous Contact Hypersensitivity by Inducing Langerhans and Dendritic Cell Migration to Lymph Nodes
J. Exp. Med., October 29, 2001; 194(9): 1219 - 1230.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Liu, R. A. Cerione, and J. Clardy
Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity
PNAS, March 5, 2002; 99(5): 2743 - 2747.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. A. Trueblood, Z. Xie, C. Communal, F. Sam, S. Ngoy, L. Liaw, A. W. Jenkins, J. Wang, D. B. Sawyer, O. H. L. Bing, et al.
Exaggerated Left Ventricular Dilation and Reduced Collagen Deposition After Myocardial Infarction in Mice Lacking Osteopontin
Circ. Res., May 25, 2001; 88(10): 1080 - 1087.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.